Acetic acid, 2-(4-chlorophenoxy)-, ethyl ester (ACI)

Ethyl 1-(phenylmethyl)-4-piperidinecarboxylate (ACI)

Ethyl 10,11-dihydro-4-methoxydibenz[b,f][1,4]oxazepine-8-carboxylate (ACI)

L-Alanine, (4S)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl ester, mono(trifluoroacetate), reaction products with polyethylene glycol bis(carboxymethyl) ether

Poly(oxy-1,2-ethanediyl), α-[(9R)-6-hydroxy-6-oxido-1,12-dioxo-9-[(1-oxotetradecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphapentacos-1-yl]-ω-methoxy-, sodium salt (1:1) (ACI)

Ethyl 2,4-dihydroxybenzoate

Curdlan (9CI, ACI)

Motilin (9CI, ACI)

Anisomelic acid

Isopropylmethylphenol

Galiximab

Immunoglobulin G1, anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal ADG126 γ1-chain), disulfide with prodomain peptide (synthetic masking moiety and protease-cleavable moiety) fusion protein with human monoclonal ADG126 κ-chain, dimer (ACI)

Immunoglobulin IgG1 Fab fragment, anti-(human and Macaca fascicularis transferrin receptors type 1) (human-Mus musculus monoclonal F5298 γ1-chain), disulfide with human-Mus musculus monoclonal F5298 κ-chain (ACI)

Immunoglobulin G4 [226-proline], anti-(human tumor necrosis factor receptor TNFRSF9) (human monoclonal ATOR-1017 γ4-chain), disulfide with human monoclonal ATOR-1017 κ-chain, dimer (ACI)

Immunoglobulin G1, anti-(human and Macaca fascicularis cytokine receptor-like factor 2) (human monoclonal UPB-101 γ1-chain), disulfide with human monoclonal UPB-101 κ-chain, dimer (ACI)

Immunoglobulin G2, anti-(human transforming growth factor β1/2) (human monoclonal clone NVS322708 γ2-chain), disulfide with human monoclonal clone NVS322708 λ1-chain, dimer (ACI)

Immunoglobulin G1 [de-C-terminal-lysine], anti-(human α-synuclein) (human monoclonal Lu AF82422 γ1-chain), disulfide with human monoclonal Lu AF82422 κ-chain, dimer (ACI)

Immunoglobulin G1 [240-alanine,241-alanine], anti-(human folate receptor α) (human monoclonal PRO1184 γ1-chain), disulfide with human monoclonal PRO1184 κ-chain, dimer (ACI)

Ranibizumab

Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 γ1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 κ-chain, dimer (ACI)